These recent advances, exploring the role of CCN5‐signaling in breast cancer, strongly suggest that targeting TNBC‐BCSC by activating CCN5 would be an ideal strategy to prevent breast tumors’ growth and relapse. This evidence concerns the gene CCN5 and breast carcinoma.